Cargando…

Prostate specific antigen (PSA) kinetic as a prognostic factor in metastatic prostate cancer receiving androgen deprivation therapy: systematic review and meta-analysis

Aim: Metastatic prostate cancer (mPCa) has a poor outcome with median survival of two to five years. The use of androgen deprivation therapy (ADT) is a gold standard in management of this stage. Aim of this study is to analyze the prognostic value of PSA kinetics of patient treated with hormonal th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Afriansyah, Andika, Hamid, Agus Rizal Ardy Hariandy, Mochtar, Chaidir Arif, Umbas, Rainy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000 Research Limited 2018
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964636/ https://www.ncbi.nlm.nih.gov/pubmed/29904592 http://dx.doi.org/10.12688/f1000research.14026.1

Ejemplares similares

The impact of obesity towards prostate diseases
por: Parikesit, Dyandra, et al.
Publicado: (2016)

Relationship of age, prostate-specific antigen, and prostate volume in Indonesian men with benign prostatic hyperplasia
por: Putra, Ida Bagus O.W., et al.
Publicado: (2016)

Outcomes and predictors of localized or locally-advanced prostate cancer treated by radiotherapy in Indonesia
por: Supit, Wempy, et al.
Publicado: (2013)

Retroperitoneoscopic proximal ureter resection and ureteroureterostomy as an alternative management for upper tract urothelial carcinoma: A case report
por: AH Hamid, Agus Rizal, et al.
Publicado: (2021)

Thrombus-like Tumor of Renal Cell Carcinoma Mimicking Transitional Cell Carcinoma of Kidney: A Case Report
por: Parikesit, Dyandra, et al.
Publicado: (2016)

Case of perinephric abscess disguising as renal tumor
por: Raharja, Putu Angga Risky, et al.
Publicado: (2018)

Meta-analysis of neoadjuvant chemotherapy compared to radical cystectomy alone in improving overall survival of muscle-invasive bladder cancer patients
por: Hamid, Agus Rizal A. H., et al.
Publicado: (2020)

Early upregulation of AR and steroidogenesis enzyme expression after 3 months of androgen-deprivation therapy
por: Hamid, Agus Rizal A. H., et al.
Publicado: (2020)

Surgical Management of Giant Genital Condyloma Acuminata by Using Double Keystone Flaps
por: Eriad Yunir, Peri, et al.
Publicado: (2016)

Transperitoneal Versus Extraperitoneal Approach for Laparoscopic and Robot-Assisted Radical Prostatectomy: A Systematic Review and Meta-Analysis
por: Purnomo, Stefanus, et al.
Publicado: (2023)

The expression of stem cells markers and its effects on the propensity for recurrence and metastasis in bladder cancer: A systematic review
por: Hamid, Agus Rizal Ardy Hariandy, et al.
Publicado: (2023)

Does Androgen Deprivation for Prostate Cancer Affect Normal Adaptation to Resistance Exercise?
por: Nilsen, Tormod S., et al.
Publicado: (2022)

Blood Transfusions in Laparoscopic Living Donor Nephrectomy: Single Center Experience from 500 Cases
por: Boentoro, Senohadi, et al.
Publicado: (2020)

Comparison between visual prostate symptom score and international prostate symptom score in males older than 40 years in rural Indonesia
por: Afriansyah, Andika, et al.
Publicado: (2014)

Prostate-Specific Antigen Kinetics Effects on Outcomes of Low-Volume Metastatic Prostate Cancer Patients Receiving Androgen Deprivation Therapy
por: Lin, Yen-Chi, et al.
Publicado: (2021)

Adherence of Indonesian urologists to practice guidelines for the management of benign prostatic hyperplasia
por: Rahman, Fakhri, et al.
Publicado: (2019)

The Protective Effect of Lycopene on Prostate Growth Inhibitory Efficacy by Decreasing Insulin Growth Factor-1 in Indonesian Human Prostate Cancer Cells
por: Tjahjodjati,, et al.
Publicado: (2020)

The Importance of Time to Prostate-Specific Antigen (PSA) Nadir after Primary Androgen Deprivation Therapy in Hormone-Naïve Prostate Cancer Patients
por: Sasaki, Takeshi, et al.
Publicado: (2018)

Adenocarcinoma mucinosum of extrophy bladder: A rare case report
por: Hamid, Agus Rizal A.H., et al.
Publicado: (2021)

The Impact of Exercise on Improving Body Composition and PSA in High-Risk Prostate Cancer Patients on Androgen-Deprivation Therapy
por: Lin, Yu-Ching, et al.
Publicado: (2022)

Renal cell carcinoma with early skin metastasis and partial response on tyrosine kinase inhibitor: A case report
por: Hamid, Agus Rizal Ardy Hariandy, et al.
Publicado: (2022)

Exercise Adherence in Men with Prostate Cancer Undergoing Androgen Deprivation Therapy: A Systematic Review and Meta-Analysis
por: Toohey, Kellie, et al.
Publicado: (2022)

Optimal PSA Threshold for Androgen-Deprivation Therapy in Patients with Prostate Cancer following Radical Prostatectomy and Adjuvant Radiation Therapy
por: Ahn, Hyun Kyu, et al.
Publicado: (2020)

Fisetin as an adjuvant treatment in prostate cancer patients receiving androgen-deprivation therapy
por: Lorenzo, Giuseppe Di, et al.
Publicado: (2022)

Addition of New Androgen Receptor Pathway Inhibitors to Docetaxel and Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer: A Systematic Review and Metanalysis
por: Fiorica, Francesco, et al.
Publicado: (2022)

Androgen deprivation and cognition in prostate cancer
por: Salminen, E, et al.
Publicado: (2003)

Neoadjuvant versus Concurrent Androgen Deprivation Therapy in Localized Prostate Cancer Treated with Radiotherapy: A Systematic Review of the Literature
por: Cartes, Rodrigo, et al.
Publicado: (2023)

Genetic polymorphisms as prognostic factors for recurrent kidney stones: A systematic review and meta-analysis
por: Atmoko, Widi, et al.
Publicado: (2021)

Renal cell carcinoma not otherwise specified: A case report in Indonesia
por: Hasan, et al.
Publicado: (2023)

Contribution of allelic variability in prostate specific antigen (PSA) & androgen receptor (AR) genes to serum PSA levels in men with prostate cancer
por: Chavan, Sushant V., et al.
Publicado: (2014)

Anxiety level of early- and late-stage prostate cancer patients
por: Johanes, Charles, et al.
Publicado: (2013)

Assessment of oligometastasis status of prostate cancer following combined robot-assisted radical prostatectomy and androgen deprivation versus androgen deprivation therapy alone using PSA percentage decline rate
por: Li, Xuwen, et al.
Publicado: (2023)

End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation and androgen deprivation therapy for prostate cancer
por: Narang, Amol K., et al.
Publicado: (2017)

Efficacy and safety of therapies for advanced prostate cancer in Asia: Evidence from a systematic literature review
por: Saad, Marniza, et al.
Publicado: (2022)

A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy
por: Lee, C Ellen, et al.
Publicado: (2012)

Decreased Risk of Renal Calculi in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer
por: Lin, Chien-Yu, et al.
Publicado: (2020)

Risk of ischemic stroke in patients with prostate cancer receiving androgen deprivation therapy in Taiwan
por: Liao, Kuang-Ming, et al.
Publicado: (2019)

Risk of esophageal and gastric adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer
por: Shore, Richard, et al.
Publicado: (2021)

Prostate cancer, insulin, and androgen deprivation therapy
por: Stattin, P, et al.
Publicado: (2003)

Risk factors of PSA progression and overall survival in patients with localized and locally advanced prostate cancer treated with primary androgen deprivation therapy
por: Tomioka, Atsushi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_s85sk87eeb0k7saiu6k31llpuu